logo
Emergent Biosolutions Inc. posts annual revenue of $1,120.90 million in 2022

Emergent Biosolutions Inc. posts annual revenue of $1,120.90 million in 2022

Key fundamental financials
  • loss of $223.80 million
  • Revenue of $1,120.90 million

By USInMinutes
Published - Apr 11, 2023, 07:40 PM ET
Last Updated - Jul 18, 2023, 03:58 PM EDT
Emergent Biosolutions Inc. [EBS] has reported $223.80 million loss for the fiscal year ending Dec 31, 2022.

Revenue for the year was $1,120.90 million with operating income of $172.70 million.

The Rockville, Maryland (MD)-based company operating in the pharmaceutical preparations sector has total shareholders equity of $1,383 million.

Also read:

This is a developing story. Click here to receive updates.
------------
NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts here.
Quick Links
Categories
Our Offices
  • 10kInfo, Inc.
    13555 SE 36th St
    Bellevue, WA 98006
  • 10kInfo Data Solutions, Pvt Ltd.
    Claywork Create
    11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
    Bengaluru, Karnataka 560076
4.2 12182024